domingo, 15 de novembro de 2026
PesquisarExplore
pt.via.news
Via News Knowledge File

Social Security Administration

government agency80% conf.·synced Aug 13, 2026

U.S. federal agency that administers Social Security retirement and disability benefits

60
sourced metrics
226
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Benefit Coverage After Depletion
81percent
Jan 1, 2034source
Benefit Payment Rate
77percent
Jan 1, 2033source
Projected Benefit Reduction
24percent
Jan 1, 2032source
Buying Power Loss
14percent
Aug 9, 2026source
Delayed Retirement Credit Rate
8percent
Jul 13, 2026source
Recommended Safe Withdrawal Rate
4percent
Jul 13, 2026source
Full Retirement Age
67years
Jul 13, 2026source
Maximum Claiming Strategy Bonus
23760USD
Jul 13, 2026source
Household Savings Rate
4percent
Jun 15, 2026source
Benefit Payable After Depletion
78percent
Jun 9, 2026source
Back Payment Coverage Months
28months
May 1, 2026source
Benefit Increase From Delaying Claim 62 To 67
43percent
May 1, 2026source
Market Share
62percent_retirees_citing_as_major_income_source
May 1, 2026source
Social Security 85pct Taxable Threshold Single
34000USD
Apr 26, 2026source
Social Security Taxability Threshold Single
25000USD
Apr 26, 2026source
Funding Deficit
169000000000USD
Mar 28, 2026source
Affected Recipients
452000recipients
Mar 1, 2026source
Average Retired Worker Benefit
2079.49USD
Mar 1, 2026source

Stated objectives

Resolve Social Security shortfall before trust fund depletion through combination of higher taxes, later claiming ages, means testing benefits, and/or changes to benefit formula

source
by 2032-01-01 00:00:00stated

Maintain Social Security solvency; program currently projected to deplete by Q4 2032 without reform

source
by 2032-10-01 00:00:00stated

Maintain solvency of Social Security trust fund

source
stated

Encourage retirement at full retirement age to receive full benefits

source
target: 67 years for those born in 1960 or later stated

Maintain full benefit payments without trust fund depletion

source
target: 100% benefit payment rate stated

Prevent loss of purchasing power for Social Security recipients by adjusting benefits to match inflation

source
stated

Strengthen Social Security's foundation for current and future beneficiaries

source
stated

Prevent Social Security insolvency expected in 2035

source
by 2035-01-01 00:00:00stated

Close the gap in Social Security trust fund through retirement age increase, benefit caps for high-income households, or immigration expansion

source
stated

Avoid depletion of Social Security trust fund through major reforms

source
target: maintain solvency by 2032-01-01 00:00:00stated

Relationship graph · 226 connections

regulates
73
Covered by
19
Customer of
17
located in
9
Built on
9
governs
8
subsidiary of
7
Supplies to
7
provides benefits to
Wealthy RetireesEvan T. Scott
covered by
SmartAsset
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,580 documentos-fonte arquivados
Consulte estes dados → isubstrate.com